Zerenex will wipe out all the competition and become Aspirin of Kidney.
$10, $15, $20, $25, $30...
Sentiment: Strong Buy
How much of that market can they capture from entrenched competition, generics and new entrants?
Then multiply that amount by a small royalty, split three ways, and let me know what you come up with.
I believe they can capture 99.99% of the market wiping out all the competition.
If you look at the data, you would prescripted right away to/ switch to Zerenex from other drugs.
KERX receives 85% of the total revenue after giving out to royalty based contracted companies.
Remember, Zerenex also met the second endpoint and in a REMARKABLE WAY. No other drugs ciurrent will have that benefits.